Literature DB >> 9040210

A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia.

M G Choi1, M Camilleri, M D O'Brien, P P Kammer, R B Hanson.   

Abstract

OBJECTIVE: Our aim was to identify qualitative or quantitative colonic motor patterns induced postprandially in a pilot study of patients with diarrhea due to functional disease or dysautonomia to identify objective endpoints for future studies.
METHODS: In patients with functional diarrhea (n = 5) or dysautonomia (n = 4) in whom GI transit was documented by scintigraphy, we studied colonic motility by combined manometry and barostat measurements for 1 h fasting and 2 h postprandially (1000-kcal meal). Data were compared with those of healthy control subjects.
RESULTS: There were no differences in compliance, overall phasic motility of the left colon, fasting tone, or maximal change in postprandial tone in the diarrhea group as compared with the control group. The diarrhea group showed more high amplitude propagated contractions 4.4 +/- 3.6 (SD)/2 h, p < 0.05) compared with the control group (0.7 +/- 1.4/2 h); the mean postprandial tonic response (12 +/- 14%, p < 0.05) and its duration were reduced in the diarrhea group compared with the control group (27 +/- 17%). Two dysautonomic patients showed a paradoxical relaxation of the colon postprandially.
CONCLUSION: Reduced duration of increased colonic tone postprandially and increased number of high amplitude propagated contractions seem to be useful objective endpoints for future studies.

Entities:  

Mesh:

Year:  1997        PMID: 9040210

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

1.  Of actors, bolting horses, and drops in oceans!

Authors:  F Cremonini; M Camilleri
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 2.  Treating irritable bowel syndrome: overview, perspective and future therapies.

Authors:  Michael Camilleri
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

3.  Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.

Authors:  B S Wong; M Camilleri; D Eckert; P Carlson; M Ryks; D Burton; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2012-01-30       Impact factor: 3.598

Review 4.  Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.

Authors:  Michael Camilleri; Lin Chang
Journal:  Gastroenterology       Date:  2008-10-09       Impact factor: 22.682

Review 5.  Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Authors:  Michael Camilleri; Joseph H Sellin; Kim E Barrett
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

Review 6.  High amplitude propagated contractions.

Authors:  A E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2012-11       Impact factor: 3.598

7.  Inhibition of gastric secretion relieves diarrhea and postprandial urgency associated with irritable bowel syndrome or functional diarrhea.

Authors:  B Dave; W Rubin
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

8.  Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial.

Authors:  Andres Acosta; Michael Camilleri; Irene Busciglio; Amy Boldingh; Alfred D Nelson; Duane Burton
Journal:  Dig Dis Sci       Date:  2015-10-14       Impact factor: 3.199

9.  Abnormalities of left colonic motility in ambulant nonconstipated patients with irritable bowel syndrome.

Authors:  C H M Clemens; M Samsom; G P Van Berge Henegouwen; A J P M Smout
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

10.  Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Sanna McKinzie; Irene Busciglio; Phillip A Low; Seth Sweetser; Duane Burton; Kari Baxter; Michael Ryks; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.